Gsk Share Discussion Threads

[cwa1] 12/3/2021 08:32

From February results:-

On track for separation into new standalone Biopharma and Consumer Healthcare companies in 2022

·2020 targets met with £0.3 billion annual cost savings and £1.1 billion divestment proceeds achieved

·Biopharma investor update in June to set out progress on innovation, commercial execution and growth outlook together with capital allocation priorities,/i>

[gaffer73] 12/3/2021 08:26

Thanks for the info. What is the split?

[montyhedge] 12/3/2021 08:08

Yes we know I think it was Credit Suisse target 50p from 80p, but hopefully growth, that's the gamble by Walmsley.

[cwa1] 12/3/2021 08:00

Just be careful re the dividend, they have announced a split and said that dividends will be lower after it

[netcurtains] 12/3/2021 07:57

I'm hoping for an up day today.

[gateside] 12/3/2021 07:57

Even better it's currently 6.4% dividend.This looks so cheap.

[gaffer73] 12/3/2021 07:51

Morning all, what's the deal with this share price dropping from 1600p? Looks like a bit of a bargain at these levels with a 6% divi.

[amt] 11/3/2021 20:42

Vir up 30% in US and doubled since January.

[netcurtains] 11/3/2021 18:04

Field Marshall surely?

[montyhedge] 11/3/2021 17:25

Professor Monty.

[spud] 11/3/2021 16:08

Dr. Monty - He's got a medical degree don't ya know!spud

[cwa1] 11/3/2021 16:05

85%? Well, it's OK, I suppose :-) You have to laugh!

[tradermichael] 11/3/2021 15:58

monty - cannot agree. This is not a vaccination, its a therapy! Under close clinical care and with other drugs, chances of survival would be higher still.

[montyhedge] 11/3/2021 15:33

Fill your boots if you think it's good.

[amt] 11/3/2021 15:24

85% stunningly good

[montyhedge] 11/3/2021 15:20

85% ok not brilliant.

[philanderer] 11/3/2021 14:44

GSK Covid treatment shows ‘profound efficacy’ in initial trial

Data from 583 patients shows 85% reduction in hospitalisation or death


GlaxoSmithKline plans to apply for emergency use authorisation for an experimental Covid-19 treatment after initial clinical trial results showed an 85 per cent reduction in hospitalisation or death.

GSK, which developed the antibody treatment with Vir Biotechnology, said separate lab tests of the drug suggested it was also effective against some of the virus variants in circulation.

[geckotheglorious] 11/3/2021 13:18

Decent RNS so tad surprised at the price action.
Oh well.

In other news, might be of interest to some.

GlaxoSmithKline plc (GSK) Presents at Barclays Global Healthcare Conference 2021 (Transcript)

[montyhedge] 11/3/2021 12:15

1225p looks on the cards. Traders selling into recent rally from 1202p taking profits.

[eurofox] 11/3/2021 11:48

VIR now up 64% in futures

[pottsypotts] 11/3/2021 11:11

Deep in the red? Take it you wasn't trading a year ago?

[tradermichael] 11/3/2021 11:09

Hardly deep in the red, net! FTSE -0.2% ...... ;0)

[spud] 11/3/2021 11:05

Deep in the red? You must have a different monitor to me! spud